SYNOPSIS: Stock declined after Q4 results and target cut, as weak revenue growth and lowered FY27 outlook offset strong profit and margin performance, raising concerns over near-term growth visibility.
During Wednesday’s trading session, shares of amongst the world’s leading providers of design led technology services and a part of Tata Group tumbled around 5 percent on BSE, after reporting its Q4 FY26 and full-year results, with Morgan Stanley cutting its target price citing a Q4 topline miss.
With a market cap of Rs. 27,625 crores, shares of Tata Elxsi Limited are currently trading in the red at Rs. 4,434.5 on BSE, down by over 4 percent, compared to its previous closing price of Rs. 4,650.3. The stock has delivered negative returns of around 19 percent in the last one year, but has gained by over 7 percent in one month.
Financial Performance Q4 FY26 & FY26
Tata Elxsi Limited announced its financial results for Q4 FY26 as well as the full financial year ended on 31st March 2026 after market hours on Tuesday, as per its latest regulatory filings with the stock exchanges.
For Q4 FY26, the company posted a revenue from operations of Rs. 994 crores, reflecting a sequential growth of around 4 percent, compared to Rs. 953 crores in Q3 FY26. On a year-on-year basis, revenue increased by nearly 9 percent from Rs. 908 crores recorded in Q4 FY25. For the full year FY26, revenue stood at Rs. 3,757 crores, reflecting a growth of just 1 percent YoY from Rs. 3,729 crores in FY25.
At the profitability level, net profit more than doubled during the quarter to Rs. 220 crores, marking an impressive growth of about 102 percent QoQ from Rs. 109 crores in Q3 FY26. Meanwhile, on a year-on-year basis, profit increased significantly by nearly 28 percent from Rs. 172 crores in Q4 FY25. For FY26, PAT stood at Rs. 628 crores, down by around 20 percent YoY from Rs. 785 crores reported in FY25.
Operational performance improved during the quarter. EBITDA stood at Rs. 244.6 crores in Q4 FY26, reflecting a slight rise of around 10 percent QoQ from Rs. 222 crores in Q3 FY26, and nearly 18 percent YoY growth from Rs. 208 crores in Q4 FY25. EBITDA margins came in at 24.6 percent, expanding by 130 basis points sequentially from 23.3 percent, and by 170 basis points on a year-on-year basis from 22.9 percent.
On a full-year basis, EBITDA stood at Rs. 846.8 crores, marking a decline of 13 percent YoY, while EBITDA margins also fell by 360 bps to 22.5 percent.
The company’s headcount stood at 12,414 in Q4 FY25, with an attrition rate of 13.3 percent. This declined to 11,594 employees in Q3 FY26, alongside a higher attrition rate of 15.6 percent. By Q4 FY26, the headcount further moderated slightly to 11,540, while attrition increased to 15.8 percent, indicating continued workforce rationalisation and elevated employee churn.
Revenue performance came in below expectations, with constant currency growth of 0.9 percent, falling short of the estimated 1.5 percent. For the full year, constant currency revenue declined by 5.5 percent. However, profitability outperformed estimates, with EBIT margin reported at 22.3 percent, exceeding the expected range of 21.5-22 percent. Additionally, the company’s Board has recommended a final dividend of Rs. 75 per equity share (750 percent) for the financial year ending 31st March 2026.
Brokerage Target, Outlook & More
Global brokerage Morgan Stanley has maintained an ‘Underweight’ rating on Tata Elxsi Limited and revised its target price downward by over 21 percent to Rs. 4,200 from Rs. 5,350 earlier. The revised target implies a downside of nearly 10 percent from the stock’s previous closing level. The brokerage noted that while Q4 performance fell short of its expectations, margins were stronger than consensus estimates.
Management has indicated a potential recovery in FY27; however, growth expectations have been moderated in light of current demand conditions. The company reported constant currency revenue growth of 0.9 percent QoQ in Q4 FY26, which was below the brokerage’s estimate of 1.5 percent. This underperformance was primarily attributed to continued weakness in the healthcare segment.
At the operating level, EBIT came in 3.4 percent below Morgan Stanley’s estimates but exceeded consensus expectations by 4 percent. Net profit, however, surpassed both estimates, supported by a lower effective tax rate.
Reflecting the softer outlook, the brokerage has revised its FY27 constant currency revenue growth estimate downward to 6.9 percent from its earlier projection of 10.4 percent.
Tata Elxsi Limited provides product design and engineering services to the consumer electronics, communications & transportation industries and systems integration and support services for enterprise customers. It also provides digital content creation for the media and entertainment industry.
In addition to the Transportation, Media & Communication, and Healthcare sectors, the company started to win engagements in semiconductor, defence and aerospace verticals during 2024-25.
Tata Elxsi aims to deliver end-to-end semiconductor solutions, combining chip design, embedded software, AI accelerators, and functional safety. It covers most of the semiconductor value chain elements with strength across chip design, embedded software, and more.
At the same time, part of the group company Tata Electronics’ semiconductor fabrication facility in Dholera Special Investment Region (SIR) represents a landmark investment of over Rs. 91,000 crore and is designed with a planned capacity of 50,000 wafer starts per month (WSPM). The Government of India, under the India Semiconductor Mission, has committed to providing 50 percent fiscal support on a pari-passu basis for eligible project costs, underscoring its strong commitment to developing a globally competitive semiconductor manufacturing ecosystem within the country.
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
